Source:http://linkedlifedata.com/resource/pubmed/id/10665657
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2000-2-28
|
pubmed:abstractText |
The interaction of docetaxel ("Taxotere") with P-glycoprotein (P-gp) was examined using porcine kidney epithelial LLC-PK1 and LLC-GA5-COL150 cells, overexpressing human P-gp selectively on the apical plasma membrane by transfection of human MDR1 cDNA into the LLC-PK1 cells. The basal-to-apical transport of [14C]docetaxel in LLC-GA5-COL150 cells significantly exceeded that in LLC-PK1 cells, but the apical-to-basal transport was decreased in LLC-GA5-COL150 cells. The intracellular accumulation after its basal or apical application to LLC-GA5-COL150 cells was 4- to 20-fold lower than that of LLC-PK1 cells. Multidrug resistance (MDR) modulators, i.e., cyclosporin A and SDZ PSC 833, inhibited the basal-to-apical transport and increased the apical-to-basal transport of [14C]docetaxel in LLC-GA5-COL150 cells, but verapamil affected only apical-to-basal transport. The intracellular accumulation after basal or apical application to LLC-GA5-COL150 cells was also increased by these three MDR modulators. These observations demonstrated that docetaxel is a substrate for human P-gp, suggesting that docetaxel-drug interactions occur via P-gp. The inhibition of [14C]docetaxel transport by the MDR modulators, as well as daunorubicin and vinblastine, was also found in LLC-PK1 cells, which endogenously express P-gp at lower levels, and concentrations showing similar levels of inhibition were lower than those in the case of LLC-GA5-COL150 cells. These observations indicate that it is necessary to consider the pharmacokinetic and pharmacodynamic interactions of docetaxel via P-gp.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0910-5050
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1380-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10665657-Animals,
pubmed-meshheading:10665657-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10665657-Biological Transport, Active,
pubmed-meshheading:10665657-Cell Line,
pubmed-meshheading:10665657-DNA, Complementary,
pubmed-meshheading:10665657-Drug Resistance, Multiple,
pubmed-meshheading:10665657-Humans,
pubmed-meshheading:10665657-Intracellular Fluid,
pubmed-meshheading:10665657-Kidney,
pubmed-meshheading:10665657-P-Glycoprotein,
pubmed-meshheading:10665657-Paclitaxel,
pubmed-meshheading:10665657-Swine,
pubmed-meshheading:10665657-Taxoids,
pubmed-meshheading:10665657-Transfection
|
pubmed:year |
1999
|
pubmed:articleTitle |
Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
|
pubmed:affiliation |
Second Department of Internal Medicine, School of Medicine, Kobe University.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|